165 related articles for article (PubMed ID: 2154819)
21. Studies on kinetics of [3H]beta-funaltrexamine binding to mu opioid receptor.
Liu-Chen LY; Li SX; Tallarida RJ
Mol Pharmacol; 1990 Feb; 37(2):243-50. PubMed ID: 2154672
[TBL] [Abstract][Full Text] [Related]
22. Evidence for mu opioid receptor mediation of enkephalin-induced electroencephalographic seizures.
Tortella FC; Robles L; Mosberg HI
J Pharmacol Exp Ther; 1987 Feb; 240(2):571-7. PubMed ID: 3027318
[TBL] [Abstract][Full Text] [Related]
23. Naloxonazine effects on the interaction of enkephalin analogs with mu-1, mu and delta opioid binding sites in rat brain membranes.
Cruciani RA; Lutz RA; Munson PJ; Rodbard D
J Pharmacol Exp Ther; 1987 Jul; 242(1):15-20. PubMed ID: 3039108
[TBL] [Abstract][Full Text] [Related]
24. Beta-[3H]funaltrexamine-labeled mu-opioid receptors: species variations in molecular mass and glycosylation by complex-type, N-linked oligosaccharides.
Liu-Chen LY; Chen C; Phillips CA
Mol Pharmacol; 1993 Oct; 44(4):749-56. PubMed ID: 8232225
[TBL] [Abstract][Full Text] [Related]
25. Opioid binding to rat and guinea-pig neural membranes in the presence of physiological cations at 37 degrees C.
Werling LL; Zarr GD; Brown SR; Cox BM
J Pharmacol Exp Ther; 1985 Jun; 233(3):722-8. PubMed ID: 2989494
[TBL] [Abstract][Full Text] [Related]
26. Cross-linking of human [125I]beta-endorphin to opioid receptors in rat striatal membranes: biochemical evidence for the existence of a mu/delta opioid receptor complex.
Schoffelmeer AN; Yao YH; Gioannini TL; Hiller JM; Ofri D; Roques BP; Simon EJ
J Pharmacol Exp Ther; 1990 Apr; 253(1):419-26. PubMed ID: 2158552
[TBL] [Abstract][Full Text] [Related]
27. Cross-linking of 125I-beta-endorphin to rat striatal mu- and delta-opioid receptors under physiological conditions: evidence for an opioid receptor complex.
Schoffelmeer AN; Yao YH; Simon EJ
Prog Clin Biol Res; 1990; 328():105-8. PubMed ID: 2154760
[No Abstract] [Full Text] [Related]
28. Characterisation of opioid binding sites using selective antagonists.
Lawrence AJ; Traynor JR
Prog Clin Biol Res; 1990; 328():121-4. PubMed ID: 1968257
[No Abstract] [Full Text] [Related]
29. Autoradiographic evidence for two classes of mu opioid binding sites in rat brain using [125I]FK33824.
Rothman RB; Jacobson AE; Rice KC; Herkenham M
Peptides; 1987; 8(6):1015-21. PubMed ID: 2831515
[TBL] [Abstract][Full Text] [Related]
30. Selective and interactive down-regulation of mu- and delta-opioid receptors in human neuroblastoma SK-N-SH cells.
Baumhaker Y; Gafni M; Keren O; Sarne Y
Mol Pharmacol; 1993 Aug; 44(2):461-7. PubMed ID: 8394999
[TBL] [Abstract][Full Text] [Related]
31. Effects of calcium-channel blockers (CCB) on mu and delta opioid receptors in rat brain membranes.
Schwarz S; Katki AG
Prog Clin Biol Res; 1990; 328():109-12. PubMed ID: 2154761
[No Abstract] [Full Text] [Related]
32. Development of delta-opioid receptors in rat brain characterised by [3H]-[D-Pen2,D-Pen5] enkephalin binding.
Kitchen I; McDowell J
NIDA Res Monogr; 1986; 75():67-8. PubMed ID: 2829009
[TBL] [Abstract][Full Text] [Related]
33. Covalent labeling of mu opioid binding site by [3H]beta-funaltrexamine.
Liu-Chen LY; Phillips CA
Mol Pharmacol; 1987 Sep; 32(3):321-9. PubMed ID: 2823089
[TBL] [Abstract][Full Text] [Related]
34. Pretreatment of rats with the irreversible mu-receptor antagonist, beta-FNA, fails to prevent naltrexone-induced upregulation of mu-opioid receptors.
Rothman RB; Long JB; Bykov V; Jacobson AE; Rice KC; Holaday JW
Neuropharmacology; 1990 Sep; 29(9):805-10. PubMed ID: 1963479
[TBL] [Abstract][Full Text] [Related]
35. Binding to mu and delta opioid sites but not kappa sites is inhibited by Fab fragments from a monoclonal antibody directed against the opioid receptor.
Bidlack JM
NIDA Res Monogr; 1986; 75():21-4. PubMed ID: 2828974
[TBL] [Abstract][Full Text] [Related]
36. Opioid receptor selectivity of beta-endorphin in vitro and in vivo: mu, delta and epsilon receptors.
Shook JE; Kazmierski W; Wire WS; Lemcke PK; Hruby VJ; Burks TF
J Pharmacol Exp Ther; 1988 Sep; 246(3):1018-25. PubMed ID: 2843623
[TBL] [Abstract][Full Text] [Related]
37. Supraspinal delta- and mu-opioid receptors mediate gastric mucosal protection in the rat.
Gyires K; Rónai AZ
J Pharmacol Exp Ther; 2001 Jun; 297(3):1010-5. PubMed ID: 11356923
[TBL] [Abstract][Full Text] [Related]
38. An examination of the opiate receptor subtypes labeled by [3H]cycloFOXY: an opiate antagonist suitable for positron emission tomography.
Rothman RB; McLean S
Biol Psychiatry; 1988 Mar; 23(5):435-58. PubMed ID: 2894229
[TBL] [Abstract][Full Text] [Related]
39. Comparative pharmacological properties and functional coupling of mu and delta opioid receptor sites in human neuroblastoma SH-SY5Y cells.
Kazmi SM; Mishra RK
Mol Pharmacol; 1987 Jul; 32(1):109-18. PubMed ID: 3037297
[TBL] [Abstract][Full Text] [Related]
40. Mu opioid receptor binding sites in human brain.
Pilapil C; Welner S; Magnan J; Zamir N; Quirion R
NIDA Res Monogr; 1986; 75():319-22. PubMed ID: 2828981
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
